Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Endocardial Stem Cells Approach Efficacy (ESCAPE)

This study has been completed.
Information provided by (Responsible Party):
Meshalkin Research Institute of Pathology of Circulation Identifier:
First received: February 10, 2009
Last updated: April 23, 2012
Last verified: April 2012